Rapport Therapeutics: fund acquires 1.19M shares
The private placement was made under a Securities Purchase Agreement dated October 28, 2026, between the issuer and both partnerships.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Rapport Therapeutics, Inc. (RAPP) reported that Third Rock Ventures V, L.P. acquired 238,095 common shares and Third Rock Ventures VI, L.P. acquired 1,190,476 common shares in a private placement on October 30, 2026, at $21 per share. Third Rock Ventures V, L.P. directly held 6,518,620 shares after the transaction; Third Rock Ventures VI, L.P. directly held 2,159,694. Reid Huber, a partner at Third Rock Ventures, serves on the issuer’s board and has been deputized to represent the reporting persons on the board.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2, F3 | 238,095 | $21.00 | $5.00M |
| Grant/Award | Common Stock F1, F3, F4 | 1,190,476 | $21.00 | $25.00M |
Footnotes (4)
- F1. Shares acquired in a private placement pursuant to a Securities Purchase Agreement dated October 28, 2026 by and between the Issuer, Third Rock Ventures V, L.P. ("TRV V") and Third Rock Ventures VI, L.P. ("TRV VI").
- F2. These shares are directly held by TRV V. The general partner of TRV V is Third Rock Ventures GP V, L.P. ("TRV GP V"). The general partner of TRV GP V is TRV GP V, LLC ("TRV GP V LLC"). Each of TRV GP V and TRV GP V LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.
- F3. Each of Reporting Persons disclaims the existence of a Section 13(d) "group" as between any TRV V related parties and any TRV VI related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties.
- F4. These shares are held directly by TRV VI. The general partner of TRV VI is Third Rock Ventures GP VI, L.P. ("TRV GP VI"). The general partner of TRV GP VI is TRV GP VI, LLC ("TRV GP VI LLC"). Each of TRV GP VI, and TRV GP VI LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.
Key Figures
Key Terms
private placement financial
Securities Purchase Agreement financial
director by deputization regulatory
beneficial ownership regulatory
pecuniary interest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.